Showing results (91-100 of 98) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Drugs|July 19, 2015
Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UKR Califano, N Tariq, S Compton, et al.Biochemical and Biophysical Research Communications|September 4, 1996
ErbB receptor activation, cell morphology changes, and apoptosis induced by anti-Her2 monoclonal antibodiesY Kita, J Tseng, T Horan, et al.Lung Cancer (Amsterdam, Netherlands)|June 24, 2015
Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancerR Lal, G N Hillerdal, R N H Shah, et al.British Journal of Cancer|July 2, 1999
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trialJ S Waters, A Norman, D Cunningham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancerA Webb, D Cunningham, J H Scarffe, et al.Inorganic Chemistry|June 29, 2019
Proton Chelating Ligands Drive Improved Chemical Separations for RhodiumHirokazu Narita, Rebecca M Nicolson, Ryuhei Motokawa, et al.European Journal of Cancer (Oxford, England : 1990)|April 15, 2014
Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: the United Kingdom Named Patient ProgrammeF Khan, C Ottensmeier, S Popat, et al.British Journal of Cancer|July 7, 2012
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II studyA Roy, D Cunningham, R Hawkins, et al.Pageof 10